Drug Profile
Influenza virus trivalent vaccine - GSK
Alternative Names: alpha-Rix; Fluarix; Fluarix Trivalent; Fluarix-VB; Inactivated influenza vaccine - GSK; Influsplit SSWLatest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Developer GSK
- Class Influenza virus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Influenza virus infections